Article info
PDFPatient Safety and Risk Management
PS-052 Incidence and description of interactions between Imatinib and other drugs in patients with Chronic Myeloid Leukaemia
Citation
PS-052 Incidence and description of interactions between Imatinib and other drugs in patients with Chronic Myeloid Leukaemia
Publication history
- First published February 24, 2014.
Online issue publication
September 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions